foxo4-dri cancer FOXO4-DRI: Human Trial Status, Research & Senolytic Data FOX04-DRI - Apollo Peptide Sciences
FOX04 DRI Apollo Peptide Sciences Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg vial Description RCpeptides FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




